-+ 0.00%
-+ 0.00%
-+ 0.00%

How Great-West Lifeco’s Stronger Earnings and Bigger Buyback Plan Will Impact Great-West (TSX:GWO) Investors

Simply Wall St·07/31/2026 08:29:18
语音播报
  • In late July 2026, Great-West Lifeco reported higher second-quarter and first-half net income and earnings per share, affirmed its common and preferred dividends, completed a CAD 925 million share buyback, and expanded its equity repurchase authorization to 40,000,000 shares.
  • Together with Empower surpassing CA$2.00 trillion in client assets and acquiring Milliman's Retirement and Benefits Administration business, these moves highlight Great-West Lifeco's focus on fee-based growth and capital return to shareholders.
  • Next, we’ll examine how this stronger earnings performance and enlarged share buyback program may reshape Great-West Lifeco’s investment narrative.

Invest in the nuclear renaissance through our list of 90 elite nuclear energy infrastructure plays powering the global AI revolution.

Great-West Lifeco Investment Narrative Recap

To own Great-West Lifeco, you need to believe in its pivot toward fee-based, capital-light businesses like Empower and its disciplined capital return. The latest results, with higher first-half net income and earnings per share plus a larger buyback, support this story in the near term. The most important short term catalyst remains how effectively Empower turns its CA$2.00 trillion of client assets into resilient fee revenue. Key risks still centre on fee pressure, competition, and execution on technology and efficiency programs.

The expanded equity repurchase authorization to 40,000,000 shares is especially relevant here. It builds on the completed CA$925 million buyback and sits alongside affirmed common and preferred dividends, underlining how closely the capital return story is tied to earnings durability. For investors focused on catalysts, this enlarged program may matter most if earnings growth in Empower and Capital and Risk Solutions continues to support ongoing repurchases without stretching the balance sheet.

Yet against this, investors should be aware that greater reliance on fee based Retirement and Wealth earnings also increases exposure to equity markets and asset flows, which could...

Read the full narrative on Great-West Lifeco (it's free!)

Great-West Lifeco's narrative projects CA$44.7 billion revenue and CA$5.3 billion earnings by 2029. This requires 7.5% yearly revenue growth and about a CA$1.0 billion earnings increase from CA$4.3 billion today.

Uncover how Great-West Lifeco's forecasts yield a CA$80.00 fair value, a 13% downside to its current price.

Exploring Other Perspectives

TSX:GWO 1-Year Stock Price Chart
TSX:GWO 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming revenue could reach about CA$45.3 billion and earnings CA$6.6 billion by 2029, so if you worry about growing concentration in capital solutions within Capital and Risk Solutions, this latest earnings beat and larger buyback may either reinforce that bullish view or prompt you to question how much good news is already in the most optimistic forecasts.

Explore 3 other fair value estimates on Great-West Lifeco - why the stock might be worth as much as 71% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Great-West Lifeco research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • Our free Great-West Lifeco research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Great-West Lifeco's overall financial health at a glance.

Want Some Alternatives?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.